Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced that it has received notification from its licensing ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Diagnosed in 2012 with prostate cancer, Tony Minter says his purpose is to share his journey with others. Now in remission, he leads a support group for men newly diagnosed and serves on the board of ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced that ISM4808, an AI-driven PHD inhibitor for ...

MELBOURNE, Australia and INDIANAPOLIS, March 10, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces ...

When Dr Samson Magesa walked away from the busy wards of Mwananyamala Hospital a decade ago, he carried with him the frustrations of a medical professional who had witnessed too many patients ...

大英博物馆通过公众募捐筹集了上百万英镑以支付购买这件珠宝。大英博物馆馆长尼古拉斯·库里南表示，公众的响应显示出人们对英国历史的高度珍视。 The pendant will join the museum's collection later this year and is expected to tour the UK.